rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0018801,
umls-concept:C0087111,
umls-concept:C0216784,
umls-concept:C0439793,
umls-concept:C0600520,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1511726,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
11
|
pubmed:dateCreated |
2004-6-2
|
pubmed:abstractText |
The objective of this study was to test the hypothesis that the severity of left ventricular remodeling predicts the response to treatment and outcomes in chronic heart failure.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0735-1097
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2022-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15172407-Antihypertensive Agents,
pubmed-meshheading:15172407-Echocardiography,
pubmed-meshheading:15172407-Heart Failure,
pubmed-meshheading:15172407-Humans,
pubmed-meshheading:15172407-Multicenter Studies as Topic,
pubmed-meshheading:15172407-Randomized Controlled Trials as Topic,
pubmed-meshheading:15172407-Retrospective Studies,
pubmed-meshheading:15172407-Severity of Illness Index,
pubmed-meshheading:15172407-Survival Analysis,
pubmed-meshheading:15172407-Tetrazoles,
pubmed-meshheading:15172407-United States,
pubmed-meshheading:15172407-Valine,
pubmed-meshheading:15172407-Ventricular Remodeling
|
pubmed:year |
2004
|
pubmed:articleTitle |
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data.
|
pubmed:affiliation |
Veterans Affairs Greater Los Angeles Healthcare System, and David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California 90073, USA. maylene.wong@med.va.gov
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|